Perioperative CA19-9 in Potentially Resectable Pancreatic Cancer: New Perspectives to Individualize Therapy

被引：0
|
作者：
Hartwig, W. [1 ]
Strobel, O. [1 ]
Hinz, U. [1 ]
Fritz, S. [1 ]
Hackert, T. [1 ]
Roth, C. [1 ]
Buechler, M. W. [1 ]
Werner, J. [1 ]
机构：
[1] Univ Heidelberg, Dept Gen Surg, D-6900 Heidelberg, Germany
来源：
PANCREAS | 2012年 / 41卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1365 / 1365
页数：1
相关论文
共 50 条
  • [1] CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
    Werner Hartwig
    Oliver Strobel
    Ulf Hinz
    Stefan Fritz
    Thilo Hackert
    Constanze Roth
    Markus W. Büchler
    Jens Werner
    Annals of Surgical Oncology, 2013, 20 : 2188 - 2196
  • [2] CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
    Hartwig, Werner
    Strobel, Oliver
    Hinz, Ulf
    Fritz, Stefan
    Hackert, Thilo
    Roth, Constanze
    Buechler, Markus W.
    Werner, Jens
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2188 - 2196
  • [3] CA19-9 as a Predictor of Resectability in Patients with Borderline Resectable Pancreatic Cancer
    He, Zhaopeng
    Lu, Huimin
    Du, Xiaojiong
    Hu, Weiming
    Tian, Bole
    Zhang, Zhaoda
    HEPATO-GASTROENTEROLOGY, 2013, 60 (124) : 900 - 903
  • [4] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
    Ferrone, Cristina R.
    Finkelstein, Dianne M.
    Thayer, Sarah P.
    Muzikansky, Alona
    Fernandez-del Castillo, Carlos
    Warshaw, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2897 - 2902
  • [5] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
    Halm, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5610 - 5610
  • [6] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Richard J. Bold
    Annals of Surgical Oncology, 2013, 20 : 2108 - 2110
  • [7] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Bold, Richard J.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2108 - 2110
  • [8] CA19-9 AND PANCREATIC-CANCER
    DUNN, PM
    MCKINSTRY, M
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (04) : 343 - 343
  • [9] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma - Reply
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5611 - 5611
  • [10] High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment
    Ushida, Yuta
    Inoue, Yosuke
    Ito, Hiromichi
    Oba, Atsushi
    Mise, Yoshihiro
    Ono, Yoshihiro
    Sato, Takafumi
    Saiura, Akio
    Takahashi, Yu
    PANCREATOLOGY, 2021, 21 (01) : 130 - 137
12345